mTOR Inhibition via Displacement of Phosphatidic Acid Induces Enhanced Cytotoxicity Specifically in Cancer Cells | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

mTOR Inhibition via Displacement of Phosphatidic Acid Induces Enhanced Cytotoxicity Specifically in Cancer Cells

Cancer Res (2018) 78 (18): 5384–5397.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Regulation of mTOR by phosphatidic acid

Maria A. Frias
Ahmet Hatipoglu
David A. Foster

Trends in Endocrinology & Metabolism (2023) 34 (3): 170.

Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling

Nobuhiro Nakazawa
Makoto Sohda
Ayaka Katayama
Munenori Ide
Yuki Shimoda
Kohei Tateno
Takayoshi Watanabe
Akihiko Sano
Makoto Sakai
Takehiko Yokobori
Hiroomi Ogawa
Tetsunari Oyama
Ken Shirabe
Hiroshi Saeki

Oncology (2023) 101 (8): 520.

In Silico and In Cell Hybrid Selection of Nonrapalog Ligands to Allosterically Inhibit the Kinase Activity of mTORC1

Raef Shams
Akihiro Matsukawa
Yukari Ochi
Yoshihiro Ito
Hideyuki Miyatake

Journal of Medicinal Chemistry (2022) 65 (2): 1329.

mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer

Obaid Afzal
Abdulmalik S. A. Altamimi
Bismillah Mubeen
Sami I. Alzarea
Waleed Hassan Almalki
Salwa D. Al-Qahtani
Eman M. Atiya
Fahad A. Al-Abbasi
Fatima Ali
Inam Ullah
Muhammad Shahid Nadeem
Imran Kazmi

International Journal of Molecular Sciences (2022) 23 (20): 12470.

Advances in autophagy as a target in the treatment of tumours

Yingying Li
Shan Gao
Xiyou Du
Jianbo Ji
Yanwei Xi
Guangxi Zhai

Journal of Drug Targeting (2022) 30 (2): 166.

FRB domain of human TOR protein induces compromised proliferation and mitochondrial dysfunction in Leishmaniadonovani promastigotes

Sudipta Chakraborty
Soumyajit Mukherjee
Priyam Biswas
Alok Ghosh
Anirban Siddhanta

Parasitology International (2022) 89: 102591.

Mapping of mTOR drug targets: Featured platforms for anti-cancer drug discovery

Raef Shams
Yoshihiro Ito
Hideyuki Miyatake

Pharmacology & Therapeutics (2022) 232: 108012.

Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays

Raef Shams
Yoshihiro Ito
Hideyuki Miyatake

International Journal of Molecular Sciences (2021) 22 (16): 8766.

AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia

Yoomi Chun
Joungmok Kim

International Journal of Molecular Sciences (2021) 22 (18): 9765.

The diversity and breadth of cancer cell fatty acid metabolism

Shilpa R. Nagarajan
Lisa M. Butler
Andrew J. Hoy

Cancer & Metabolism (2021) 9 (1)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Zhilin Zou
Tao Tao
Hongmei Li
Xiao Zhu

Cell & Bioscience (2020) 10 (1)

Phospholipase D as a key modulator of cancer progression

Yuanfa Yao
Xinyi Wang
Hanbing Li
Jiannan Fan
Xiaohan Qian
Hong Li
Yingke Xu

Biological Reviews (2020) 95 (4): 911.

Polydopamine-capped AgNPs as a novel matrix overcoming the ion suppression of phosphatidylcholine for MALDI MS comprehensive imaging of glycerophospholipids and sphingolipids in impact-induced injured brain

Chao Han
Shumu Li
Qingwei Yue
Na Li
Hui Yang
Zhenwen Zhao

The Analyst (2019) 144 (21): 6304.